{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:35:56Z","timestamp":1780104956892,"version":"3.54.0"},"reference-count":49,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019134","name":"Central University of Ecuador","doi-asserted-by":"crossref","award":["DI-CONV-2019-035"],"award-info":[{"award-number":["DI-CONV-2019-035"]}],"id":[{"id":"10.13039\/100019134","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Type 2 diabetes mellitus (T2D) is a chronic metabolic disorder in which inflammation plays a central role in its onset, progression, and complications. Identifying reliable biomarkers is essential to improve risk prediction, disease monitoring, and early intervention. A total of 169 Ecuadorian participants were stratified into four clinical groups: non-diabetic controls (NDC), controlled T2D (C-T2D), uncontrolled T2D (NC-T2D), and diabetic kidney disease (DKD). Circulating levels of cytokines (IL-6, IL-8, TNF-\u03b1), adipokines (leptin, adiponectin), and PBMC-derived microRNAs (miR-146a, miR-155) were quantified. Associations with disease stage were evaluated using ROC curve analysis and logistic regression. Leptin showed the strongest association with T2D (OR = 13.76, 95% CI: 6.47\u201329.26), followed by IL-8 (OR = 6.73, 95% CI: 3.30\u201313.70) and IL-6 (OR = 4.43, 95% CI: 2.26\u20138.97). Adiponectin distinguished NC-T2D from DKD (OR = 4.15, 95% CI: 1.77\u20139.71), underscoring its potential as an indicator of renal complications. Interestingly, TNF-\u03b1 levels declined across disease stages, possibly reflecting subclinical inflammation in Ecuadorian NDC with high rates of obesity and dyslipidemia. PBMC-derived miR-146a was upregulated in T2D patients, contrasting with prior serum-based studies and emphasizing the importance of compartment-specific analysis. miR-155 was elevated in C-T2D, suggesting a compensatory immune-regulatory mechanism that diminishes with poor glycemic control and advanced disease. Inflammatory cytokines, adipokines, and microRNAs act in distinct yet complementary ways in T2D. Leptin, IL-6, and IL-8 emerge as strong predictors of disease, while miR-146a and miR-155 provide additional insight into immune-inflammatory regulation. Integrated biomarker panels may enhance patient stratification and support personalized monitoring of T2D progression.<\/jats:p>","DOI":"10.3390\/cimb47100859","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T16:13:03Z","timestamp":1760717583000},"page":"859","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Linkage Between Inflammation and the Progression of Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0447-0136","authenticated-orcid":false,"given":"Lucy","family":"Balde\u00f3n-Rojas","sequence":"first","affiliation":[{"name":"Research Institute of Biomedicine, Central University of Ecuador, Quito 170201, Ecuador"},{"name":"Faculty of Medicine, Central University of Ecuador, Quito 170403, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Alulema","sequence":"additional","affiliation":[{"name":"Research Institute of Biomedicine, Central University of Ecuador, Quito 170201, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5954-9696","authenticated-orcid":false,"given":"Francisco","family":"Barrera-Guarderas","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Pontifical Catholic University of Ecuador, Quito 170143, Ecuador"},{"name":"Internal Medicine Department, Hospital Julio Endara, Ministry of Health, Quito 170801, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4890-2755","authenticated-orcid":false,"given":"Diana","family":"Aguirre-Villac\u00eds","sequence":"additional","affiliation":[{"name":"Research Institute of Biomedicine, Central University of Ecuador, Quito 170201, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1332-6459","authenticated-orcid":false,"given":"Cristina","family":"Ca\u00f1adas-Herrera","sequence":"additional","affiliation":[{"name":"Research Institute of Biomedicine, Central University of Ecuador, Quito 170201, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2293-8879","authenticated-orcid":false,"given":"Ricardo","family":"Bed\u00f3n-Galarza","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Central University of Ecuador, Quito 170403, Ecuador"},{"name":"Internal Medicine Department, Hospital General Docente de Calder\u00f3n, Quito 170201, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"P\u00e9rez-Tasigchana","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n en Salud P\u00fablica y Epidemiolog\u00eda Cl\u00ednica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170129, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2742-3727","authenticated-orcid":false,"given":"Jorge","family":"P\u00e9rez-Galarza","sequence":"additional","affiliation":[{"name":"Research Institute of Biomedicine, Central University of Ecuador, Quito 170201, Ecuador"},{"name":"Faculty of Medicine, Central University of Ecuador, Quito 170403, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"ref_1","unstructured":"Magliano, D.J., Boyko, E.J., and IDF Diabetes Atlas 10th Edition Scientific Committee (2021). IDF DIABETES ATLAS [Internet], International Diabetes Federation. [10th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41591-023-02278-8","article-title":"Global Dietary Database. Incident type 2 diabetes attributable to suboptimal diet in 184 countries","volume":"29","author":"Cudhea","year":"2023","journal-title":"Nat. Med."},{"key":"ref_3","unstructured":"Instituto Nacional de Estad\u00edsticas y Censos (INEC) (2025, September 01). Bolet\u00edn T\u00e9cnico Registro Estad\u00edstico de Defunciones Generales. Available online: https:\/\/www.ecuadorencifras.gob.ec\/documentos\/web-inec\/Poblacion_y_Demografia\/Defunciones_Generales\/2023\/Boletin_EDG_2023.pdf."},{"key":"ref_4","unstructured":"World Health Organization (WHO) (1999). Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications, World Health Organization (WHO), Department of Noncommunicable Disease Surveillance."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic Kidney Disease: Challenges, Progress, and Possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"124","author":"Reidy","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.med.2016.09.003","article-title":"Complicaciones microvasculares de la diabetes","volume":"12","author":"Llavero","year":"2016","journal-title":"Med\u2014Programa Form. M\u00e9dica Contin. Acreditado"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0272-6386(99)70035-1","article-title":"End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions","volume":"34","author":"Ritz","year":"1999","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/CS20120198","article-title":"Inflammation and the pathogenesis of diabetic nephropathy","volume":"124","author":"Wada","year":"2013","journal-title":"Clin. Sci. Lond. Engl."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","article-title":"Innate immunity in diabetic kidney disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Donate-Correa, J., Ferri, C.M., S\u00e1nchez-Quintana, F., P\u00e9rez-Castro, A., Gonz\u00e1lez-Luis, A., Mart\u00edn-N\u00fa\u00f1ez, E., Mora-Fern\u00e1ndez, C., and Navarro-Gonz\u00e1lez, J.F. (2020). Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications. Front. Med., 7.","DOI":"10.3389\/fmed.2020.628289"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Zhao, L., Zou, Y., and Liu, F. (2020). Transforming Growth Factor-Beta1 in Diabetic Kidney Disease. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00187"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41418-022-01062-4","article-title":"Cell death and inflammation during obesity: \u201cKnow my methods, WAT(son)\u201d","volume":"30","author":"Hildebrandt","year":"2023","journal-title":"Cell Death Differ."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/jdi.12828","article-title":"Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy","volume":"9","author":"Liu","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hung, P.H., Hsu, Y.C., Chen, T.H., and Lin, C.L. (2021). Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111857"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e0173918","DOI":"10.1371\/journal.pone.0173918","article-title":"miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","article-title":"MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development","volume":"33","author":"Kahn","year":"2010","journal-title":"Immunity"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102041","DOI":"10.1016\/j.omtn.2023.102041","article-title":"A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease","volume":"34","author":"Prieto","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"D\u2019Marco, L., Puchades, M.J., Gorriz, J.L., Romero-Parra, M., Lima-Mart\u00ednez, M., Soto, C., Bermudez, V., and Raggi, P. (2020). Epicardial Adipose Tissue, Adiponectin and Leptin: A Potential Source of Cardiovascular Risk in Chronic Kidney Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030978"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Korczynska, J., Czumaj, A., Chmielewski, M., Swierczynski, J., and Sledzinski, T. (2021). The Causes and Potential Injurious Effects of Elevated Serum Leptin Levels in Chronic Kidney Disease Patients. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094685"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zorena, K., Jachimowicz-Duda, O., \u015al\u0119zak, D., Robakowska, M., and Mrugacz, M. (2020). Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103570"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2011). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 34, S62.","DOI":"10.2337\/dc11-S062"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1399-5618.2006.00359.x","article-title":"A relative resistance of T cells to dexamethasone in bipolar disorder","volume":"8","author":"Knijff","year":"2006","journal-title":"Bipolar Disord."},{"key":"ref_25","first-page":"e64619","article-title":"Serum Tumor Necrosis Factor Alpha (TNF-\u03b1) Levels in Obese and Overweight Adults: Correlations With Metabolic Syndrome and Inflammatory Markers","volume":"16","author":"Eswar","year":"2024","journal-title":"Cureus"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40618-020-01267-9","article-title":"Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: The ENSANUT-ECU study","volume":"44","author":"Franco","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"Boden","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_29","first-page":"370","article-title":"Interleukin 8 and diabetic nephropathy","volume":"7","author":"Ene","year":"2015","journal-title":"HVM Bioflux"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"154804","DOI":"10.1016\/j.metabol.2021.154804","article-title":"The IL-8-CXCR1\/2 axis contributes to diabetic kidney disease","volume":"121","author":"Loretelli","year":"2021","journal-title":"Metabolism"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cyto.2011.09.029","article-title":"Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: A cross-sectional study","volume":"57","author":"Mirza","year":"2012","journal-title":"Cytokine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2017.03.003","article-title":"IL-6 signaling in diabetic nephropathy: From pathophysiology to therapeutic perspectives","volume":"37","year":"2017","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.krcp.2016.09.003","article-title":"The role of local IL6\/JAK2\/STAT3 signaling in high glucose-induced podocyte hypertrophy","volume":"35","author":"Jo","year":"2016","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.bbrc.2013.05.046","article-title":"Sequential signaling cascade of IL-6 and PGC-1\u03b1 is involved in high glucose-induced podocyte loss and growth arrest","volume":"435","author":"Kim","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2337\/dc11-1039","article-title":"Association of serum leptin levels with progression of diabetic kidney disease in patients with type 2 diabetes","volume":"34","author":"Hanai","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s001250051001","article-title":"Plasma leptin concentrations: No difference between diabetic Pima Indians with and without nephropathy","volume":"41","author":"Wilson","year":"1998","journal-title":"Diabetologia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3904\/kjim.2019.109","article-title":"Adiponectin for the treatment of diabetic nephropathy","volume":"34","author":"Lee","year":"2019","journal-title":"Korean J. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.biochi.2012.02.024","article-title":"The complex role of adiponectin in chronic kidney disease","volume":"94","author":"Jia","year":"2012","journal-title":"Biochimie"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Szostak, J., Gor\u0105cy, A., Durys, D., Dec, P., Modrzejewski, A., and Pawlik, A. (2023). The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076214"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e115209","DOI":"10.1371\/journal.pone.0115209","article-title":"Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients","volume":"9","author":"Weigelt","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Xie, Y., Chu, A., Feng, Y., Chen, L., Shao, Y., Luo, Q., Deng, X., Wu, M., Shi, X., and Chen, Y. (2018). MicroRNA-146a: A Comprehensive Indicator of Inflammation and Oxidative Stress Status Induced in the Brain of Chronic T2DM Rats. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00478"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2587104","DOI":"10.1155\/2023\/2587104","article-title":"Association of MicroRNA-146a with Type 1 and 2 Diabetes and their Related Complications","volume":"2023","author":"Ghaffari","year":"2023","journal-title":"J. Diabetes Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1681\/ASN.2015010111","article-title":"Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy","volume":"27","author":"Bhatt","year":"2016","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Gilyazova, I., Asadullina, D., Kagirova, E., Sikka, R., Mustafin, A., Ivanova, E., Bakhtiyarova, K., Gilyazova, G., Gupta, S., and Khusnutdinova, E. (2023). MiRNA-146a\u2014A Key Player in Immunity and Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612767"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"MicroRNAs in Metabolism and Metabolic Disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1194\/jlr.M062497","article-title":"miR-146a-5p inhibits TNF-\u03b1-induced adipogenesis via targeting insulin receptor in primary porcine adipocytes","volume":"57","author":"Wu","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13098-015-0113-5","article-title":"Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574\u20133p, in monocytes and serum of patients with T2D","volume":"8","author":"Weigelt","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e141022209958","DOI":"10.2174\/1573399819666221014095715","article-title":"MIRNA146a And Diabetes-Related Complications: A Review","volume":"19","author":"Maratni","year":"2023","journal-title":"Curr. Diabetes Rev."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Ren, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H.R., and Gao, D. (2022). Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.873699"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/10\/859\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:12:49Z","timestamp":1761192769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/10\/859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["cimb47100859"],"URL":"https:\/\/doi.org\/10.3390\/cimb47100859","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}